ADXN Proyeksi bathi mangsa ngarep Addex
Addex Therapeutics (ADXN) faces patent threats and a dependency on its partnership with Janssen, making test results critical. The organization's future profit trend visualizes these risks, while 0.00 shows the value of this parameter. The company is diversifying its portfolio by targeting epilepsy and Parkinson's disease. Growth prospects are based on the creation of innovative allosteric modulators in collaboration with global behemoths.
Rincian analitis perusahaan Addex Therapeutics (ADXN)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi pasar:
- indikator kapitalisasi buku:
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Addex Therapeutics|ADXN - Rasio utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Addex Therapeutics|ADXN - Kewajiban utang agregat|Utang marang nilai buku Addex Therapeutics|ADXN - Gedhene kewajiban jangka dawa|Utang jangka cendhak perusahaan Addex Therapeutics|Rasio cepet addextherapeutics.com
- informasi bathi lan kelipatan valuasi:
ADXN - Penghasilan resik perusahaan|Bathi sing dikarepake Addex Therapeutics|ADXN - Nilai perusahaan marang bathi resik|Pangali Forward P/E Addex Therapeutics Ltd.|ADXN - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Addex Therapeutics Ltd|ADXN - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi resik saben saham (EPS TTM) Addex Therapeutics|ADXN - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan addextherapeutics.com|ADXN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Addex Therapeutics
- rincian pendapatan lan dodolan emiten:
Pambiji fundamental perusahaan:Addex Therapeutics
When constructing a long-term portfolio, fundamental screening requires a precise analysis of future cash flows. This metric calculates a mathematical projection of net income, excluding subjective market expectations. For Addex Therapeutics (ADXN), this calculation is based on the commercialization of its allosteric modulator platform in neurology. The integration of innovations in the treatment of neurodegenerative diseases directly determines the dynamics of this indicator. Monitor the projected net profit growth to assess drawdown risks.
Pesaing langsung
BIIB (Biogen) - Proyeksi bathi mangsa ngarep|Prakiraan bathi resik NBIX (Neurocrine Biosciences, Inc.)|Proyeksi bathi mangsa ngarep RGC|Axsome Corp - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep ACAD (ACADIA Corp)|XENE: Prakiraan bathi resik|Viking Therapeutics Inc - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Supernus Pharmaceuticals, Inc.|Catalyst Pharmaceuticals Inc (CPRX) - Bathi sing dikarepake|DNLI (Denali Therapeutics Inc) - Bathi sing dikarepake|Bathi sing dikarepake Harmony Biosciences Holdings, Inc.|Bathi sing dikarepake BHVN|Bathi mangsa ngarep AMLX (Amylyx Pharmaceuticals, Inc.)|Bathi resik mangsa ngarep TRVI|Bathi sing dikarepake Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Bathi sing dikarepake|CBLL: Bathi mangsa ngarep|Penghasilan resik sing dikarepake PRTA (prothena.com)|Alector, Inc. (ALEC) - Bathi sing dikarepake|Prakiraan bathi resik ANNX|Bathi sing dikarepake Omeros Corp.|Neurogene Therapeutics (NGNE) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep ACIU|VYGR (Voyager Therapeutics) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep NMRA (neumoratx.com)|SCLX: Prakiraan bathi resik|TVGN - Bathi sing dikarepake|Bathi resik sing dikarepake Alpha Cognition Inc.|CGTX: Proyeksi bathi mangsa ngarep|inhibikase.com (IKT) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Cassava Sciences Inc|ASRT - Proyeksi bathi resik|Bathi sing dikarepake Coya (COYA)|Proyeksi bathi mangsa ngarep VistaGen Therapeutics Inc (VTGN)|Ovid Therapeutics Inc. - Bathi mangsa ngarep|Prakiraan bathi perusahaan Acumen Pharmaceuticals (ABOS)|CervoMed Corporation - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan alteritytherapeutics.com ATHE|CLNN: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake PepGen Corp (PEPG)|Bathi sing dikarepake Jupiter Neurosciences, Inc.|RLMD: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep ANVS|Bathi mangsa ngarep Grace Tx GRCE|Bathi sing dikarepake Firefly Neuroscience, Inc AIFF|KLTO: Prakiraan bathi resik|NRSN - Bathi sing dikarepake|RVPH: Bathi sing dikarepake|MTVA (MetaVia Inc.) - Bathi mangsa ngarep|NeurAxis Inc. (NRXS) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Helius Medical|Passage Bio, Inc. - Bathi forward|Bathi mangsa ngarep NEUP (Neuphoria)|NERV - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ATHA (athira.com)|Alzamend (ALZN) - Bathi resik sing dikarepake|CYCN: Bathi mangsa ngarep|Bathi resik sing dikarepake Protagenic Therapeutics Inc.|pasitheaclinics.com (KTTA) - Bathi sing dikarepake|Bathi resik sing dikarepake Cortigent Medical (CRGT)|ATXI (Avenue Therapeutics Inc) - Proyeksi bathi mangsa ngarep|BCLI (Brainstorm Cell Therapeutics Inc.) - Bathi resik mangsa ngarep|Proyeksi bathi mangsa ngarep CARA|CHRO - Bathi resik sing dikarepake|Eliem Therapeutics - Bathi mangsa ngarep|Intra-Cellular (ITCI) - Bathi resik sing dikarepake|LBPH - Bathi sing dikarepake|MRNS - Proyeksi bathi mangsa ngarep|NKGN: Proyeksi bathi mangsa ngarep|NeuroBo Pharma (NRBO) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep SAGE|Prakiraan bathi resik SNPX (Synaptogenix, Inc.)|Bathi sing dikarepake Trevena, Inc (TRVN)|VIGL (Vigil Neuroscience Inc.) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Anew Medical WENA|Bathi resik mangsa ngarep CERE (Cerevel)
